We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Kindred Healthcare Acquires Gentiva Health Services

By HospiMedica International staff writers
Posted on 15 Feb 2015
Kindred Healthcare (Louisville, KY, USA) has completed the acquisition of Gentiva Health Services (Atlanta, GA, USA), in a deal that will turn Kindred into the fourth largest operator of long-term acute care hospitals and inpatient rehabilitation facilities in the United States. More...
The deal was concluded for about USD 720 million in cash and stock, but when including the assumption of outstanding, it is valued at USD 1.8 billion.

The combined company will have 109,000 employees in hundreds of long-term acute-care hospitals, inpatient rehabilitation facilities, skilled-nursing facilities, and hospices. It is projected to have annual revenue of about USD 7.1 billion, with 70% coming from government programs such as Medicare and Medicaid, despite recent payment cuts for many services. Kindred Healthcare expects, however, that the combined company will find good sales-growth opportunities due to the aging population and the health-care system’s push to transfer more care into patients’ homes.

Gentiva, a large provider of hospice services and at-home nursing care and physical therapy, also offers skilled nursing, physical, occupational, speech and neurorehabilitation services, in addition to hospice services. It is also involved in social work, nutrition, disease management education, and other therapies and services. The company had downsized in recent quarters amid the tougher federal reimbursement, prompting Kindred to initiate a hostile takeover in July 2014. Gentiva rejected several of Kindred's bids up to the merger offer.

“Kindred now has an expanded breadth of offerings, broad geographic footprint, and enhanced presence in our integrated care markets that we believe will drive more efficient and cost-effective coordinated care,” said Benjamin Breier, president of Kindred Healthcare. “We are pleased with the strong operating trends in both companies in the back half of 2014 and strong momentum going into 2015.”

“Over the last eight weeks, we undertook a robust due diligence process and worked closely and constructively with our counterparts at Gentiva to better understand their operations, financial results, and outlook,” said Paul Diaz, CEO of Kindred Healthcare. “This process confirmed the compelling strategic rationale and industrial logic of this combination, as well as our belief that this transaction is in the best interests of both companies and our respective shareholders, patients, employees and business partners.”

Related Links:

Kindred Healthcare
Gentiva Health Services



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.